跳轉至內容
Merck
全部照片(1)

重要文件

20229

Supelco

ORBO 活性硅胶管

W,W,F separators, O.D. × L 6 mm × 75 mm, pkg of 50 ea

同義詞:

ORBO 52 小活化硅胶 (20/40) 150/75 mg,pk 50

登入查看組織和合約定價


About This Item

分類程式碼代碼:
47131900
暫時無法取得訂價和供貨情況

材料

W,W,F separators
silica gel

品質等級

agency

NIOSH 2002,2003,2004,2005,2010,2013,2014
OSHA 16,21

產品線

ORBO

成份

Bed A, 150 mg
Bed B, 75 mg

包裝

pkg of 50 ea

製造商/商標名

ORBO 52 Small

技術

active air sampling: suitable

外徑 × 長度

6 mm × 75 mm

基質

Activated silica gel

粒徑

20-40 mesh

應用

air monitoring
environmental
industrial hygiene

尋找類似的產品? 前往 產品比較指南

一般說明

  • ORBO 52 小活化硅胶 (20/40) 150/75 mg 溶剂解吸管设计用于气体和蒸汽取样。
  • 它包含两个由玻璃棉或泡沫分离的相同选择性吸附剂的床。
  • 双层结构或双床结构的球管允许在更小的备用床中捕获任何样本穿透。

法律資訊

ORBO is a trademark of Sigma-Aldrich Co. LLC

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

nwg

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

K Flo et al.
Scandinavian journal of clinical and laboratory investigation, 55(8), 715-721 (1995-12-01)
Elevated extracellular cGMP levels have been observed in various clinical conditions, and the analyte has been proposed as a diagnostic marker of cardiovascular as well as malignant diseases. However, the use of extracellular cGMP as a pathophysiological marker requires detailed
Bjørn T Moe et al.
Anticancer research, 29(4), 1047-1052 (2009-05-06)
Endometrial hyperplasia is a precursor lesion of endometrial carcinoma. Clinical studies of endometrial hyperplasia have shown that levonorgestrel (LNG) is more therapeutically effective than medroxyprogesterone acetate (MPA). The present pharmacological in vitro study was performed to compare progestin effects on
A Orbo et al.
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 117(7), 972-976 (1997-03-10)
The development of female steroid hormone-related neoplasms such as gynaecologic and mammary cancers is influenced by hormones administered exogenously. Hormonal contraceptives and hormone replacement therapy both affect the risk of developing cancers in the endometrium, cervix, ovarium, and mammary glands.
Anne Ørbo et al.
The Journal of steroid biochemistry and molecular biology, 113(1-2), 139-149 (2009-01-14)
Patients with endometrial hyperplasia representing preliminary stages of endometrial cancer have shown to respond to therapy in 100% of the cases when treated with levonorgestrel-impregnated intrauterine device. Anti-proliferative effect has also been reported after application of an anti-progestin impregnated intrauterine
A Orbo et al.
International journal of oncology, 5(3), 619-625 (1994-09-01)
About 50% of the cases with invasive carcinoma of the uterine cervix occurs before menopause. Cyclic changes of sex steroids may therefore interfere with the ratio between extracellular levels of cGMP and cAMP (cGMP(ex)/cAMP(ex)). This ratio has been proposed as

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務